Sunday, 11 October 2026European Markets

MELHUS SPAREBANK And CRCAM BRIE PIC2CCI Have A High Dividend Yield And Return On Equity In The Financial Services Sector.

Loading stream...

(vianews) - melhus sparebank (melg.ol) is among this list of stock assets with the highest dividend rate and return on equity on the financial services sector.

financial asset price forward dividend yield return on equity
melhus sparebank (melg.ol) kr156.00 6.92% 10.56%
crcam brie pic2cci (crbp2.pa) €18.80 5.48% 3.64%

several euronext companies pay out dividends to its shareholders. the dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.

1. melhus sparebank (melg.ol)

6.92% forward dividend yield and 10.56% return on equity

melhus sparebank, a savings bank, provides various banking products and services to companies, agriculture customers, and private individuals in norway. the company offers savings accounts; construction and business loans; bank guarantee, overdraft, and leasing services; and credit and bank cards. it also provides various insurance products for liability, health, personnel, occupational injury, travel, accident, business, store, data attack, property damage, craftsman, homeowners, office, vehicle, and farms; savings and pension products; payment services; and online and mobile banking services. the company operates through branch offices in central trondheim, heimdal, ler, and korsvegen. melhus sparebank was founded in 1840 and is headquartered in melhus, norway.

earnings per share

as for profitability, melhus sparebank has a trailing twelve months eps of kr16.44.

pe ratio

melhus sparebank has a trailing twelve months price to earnings ratio of 9.49. meaning, the purchaser of the share is investing kr9.49 for every norwegian krone of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 10.56%.

more news about melhus sparebank.

2. crcam brie pic2cci (crbp2.pa)

5.48% forward dividend yield and 3.64% return on equity

caisse régionale de crédit agricole mutuel brie picardie société coopérative provides a range of banking and financial products and services to individuals, farmers, professionals, businesses, and local authorities in france. it offers savings support comprising monetary, bonds, and securities; and life insurance investments, as well as housing and consumer loans; payment services; and property and casualty insurance, provident insurance products, and life insurance products. the company was founded in 2005 and is headquartered in amiens, france. caisse régionale de crédit agricole mutuel brie picardie société coopérative operates as a subsidiary of crédit agricole s.a.

pe ratio

crcam brie pic2cci has a trailing twelve months price to earnings ratio of 1.67. meaning, the purchaser of the share is investing €1.67 for every euro of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 3.64%.

yearly top and bottom value

crcam brie pic2cci's stock is valued at €18.80 at 07:30 est, below its 52-week high of €20.10 and way above its 52-week low of €16.90.

more news about crcam brie pic2cci.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Agentic AI Rewires Enterprise Software: Platform Incumbents, Governance, and a Funded Startup Wave
Enterprise software is being rebuilt around autonomous AI agents. Incumbents and large platforms (SAP with its Autonomous Suite and Joule, Zeta with AthenaOS/AIM/Athena MCP, Meta with its new Enterprise Platform) are racing to own the agent layer. Meanwhile, seed and Series A money flows to finance-office and vertical startups (Dextr, Latitude, Dentira, Light), and consolidation continues through acquisitions (Tiny–Oso Cloud, Harvey–Guardrails AI). Investor commentary stresses that AI is better at disrupting around the edges of systems of record than at replacing them, that it should not be trusted with finance calculations, and that governance must be enforced by the system rather than left to agents.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,369 source documents archived
Query this data → isubstrate.com